Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

Pancreatic Neuroendocrine Tumor Clinical Trial

Official title:

Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02624154
• Other study ID #: SYSU 211
• Status: Not yet recruiting
• Phase: N/A
• First received: November 30, 2015
• Last updated: December 4, 2015
• Start date: December 2015
• Est. completion date: December 2016

Study information

• Verified date: November 2015
• Source: First Affiliated Hospital, Sun Yat-Sen University
• Contact: Qinchang Chen, Doctor
• Phone: 18819430530
• Email: 337809622[@]qq.com
• Is FDA regulated: No
• Health authority: China: Health and Family Planning Commission of Guangdong Province
• Study type: Observational

Clinical Trial Summary

Investigator determined the factor of surgery associated with the survival of pancreatic neuroendocrine tumor.

Description:

The variables including clinical characteristics, surgical data and pathological findings are examined by univariate and multivariate analyses.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2
• Est. completion date: December 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 10 Years to 80 Years

Eligibility

Inclusion Criteria:

• The patients with pancreatic neuroendocrine tumor underwent pancreatectomy

Exclusion Criteria:

• The patients with pancreatic neuroendocrine tumor did not undergo pancreatectomy

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Carcinoid Tumor
• Neuroendocrine Tumors
• Pancreatic Neuroendocrine Tumor

Intervention

Procedure:
• pancreatectomy
Remove the pancreatic neuroendocrine tumor by surgery

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
First Affiliated Hospital, Sun Yat-Sen University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The survival rate		3 years	Yes